These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23897618)

  • 1. Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA.
    Ferraro B; Talbott KT; Balakrishnan A; Cisper N; Morrow MP; Hutnick NA; Myles DJ; Shedlock DJ; Obeng-Adjei N; Yan J; Kayatani AK; Richie N; Cabrera W; Shiver R; Khan AS; Brown AS; Yang M; Wille-Reece U; Birkett AJ; Sardesai NY; Weiner DB
    Infect Immun; 2013 Oct; 81(10):3709-20. PubMed ID: 23897618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults.
    Anum D; Kusi KA; Ganeshan H; Hollingdale MR; Ofori MF; Koram KA; Gyan BA; Adu-Amankwah S; Badji E; Huang J; Belmonte M; Banania GJ; Kwofie TB; Villasante E; Dodoo D; Sedegah M
    Malar J; 2015 Jan; 14():20. PubMed ID: 25604473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards large-scale identification of HLA-restricted T cell epitopes from four vaccine candidate antigens in a malaria endemic community in Ghana.
    Kusi KA; Ofori EA; Akyea-Mensah K; Kyei-Baafour E; Frimpong A; Ennuson NA; Belmonte M; Ganeshan H; Huang J; Amoah LE; Villasante E; Sedegah M
    Vaccine; 2022 Jan; 40(5):757-764. PubMed ID: 34969544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates.
    Pichyangkul S; Kum-Arb U; Yongvanitchit K; Limsalakpetch A; Gettayacamin M; Lanar DE; Ware LA; Stewart VA; Heppner DG; Mettens P; Cohen JD; Ballou WR; Fukuda MM
    Infect Immun; 2008 Jan; 76(1):229-38. PubMed ID: 17954725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
    Chuang I; Sedegah M; Cicatelli S; Spring M; Polhemus M; Tamminga C; Patterson N; Guerrero M; Bennett JW; McGrath S; Ganeshan H; Belmonte M; Farooq F; Abot E; Banania JG; Huang J; Newcomer R; Rein L; Litilit D; Richie NO; Wood C; Murphy J; Sauerwein R; Hermsen CC; McCoy AJ; Kamau E; Cummings J; Komisar J; Sutamihardja A; Shi M; Epstein JE; Maiolatesi S; Tosh D; Limbach K; Angov E; Bergmann-Leitner E; Bruder JT; Doolan DL; King CR; Carucci D; Dutta S; Soisson L; Diggs C; Hollingdale MR; Ockenhouse CF; Richie TL
    PLoS One; 2013; 8(2):e55571. PubMed ID: 23457473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-Directed AAV8 Booster Vaccine Expressing
    Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
    Front Immunol; 2021; 12():612910. PubMed ID: 34248928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring
    Waghela IN; Mallory KL; Taylor JA; Schneider CG; Savransky T; Janse CJ; Lin PJC; Tam YK; Weissman D; Angov E
    Front Immunol; 2022; 13():1026052. PubMed ID: 36591298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
    Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
    Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.
    Richie TL; Charoenvit Y; Wang R; Epstein JE; Hedstrom RC; Kumar S; Luke TC; Freilich DA; Aguiar JC; Sacci JB; Sedegah M; Nosek RA; De La Vega P; Berzins MP; Majam VF; Abot EN; Ganeshan H; Richie NO; Banania JG; Baraceros MF; Geter TG; Mere R; Bebris L; Limbach K; Hickey BW; Lanar DE; Ng J; Shi M; Hobart PM; Norman JA; Soisson LA; Hollingdale MR; Rogers WO; Doolan DL; Hoffman SL
    Hum Vaccin Immunother; 2012 Nov; 8(11):1564-84. PubMed ID: 23151451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.
    Tewari K; Flynn BJ; Boscardin SB; Kastenmueller K; Salazar AM; Anderson CA; Soundarapandian V; Ahumada A; Keler T; Hoffman SL; Nussenzweig MC; Steinman RM; Seder RA
    Vaccine; 2010 Oct; 28(45):7256-66. PubMed ID: 20846528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
    Bettencourt P
    Front Immunol; 2020; 11():190. PubMed ID: 32153565
    [No Abstract]   [Full Text] [Related]  

  • 12. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines.
    Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei.
    Bergmann-Leitner ES; Mease RM; De La Vega P; Savranskaya T; Polhemus M; Ockenhouse C; Angov E
    PLoS One; 2010 Aug; 5(8):e12294. PubMed ID: 20808868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites.
    Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES
    Malar J; 2019 May; 18(1):186. PubMed ID: 31142328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.
    Brando C; Ware LA; Freyberger H; Kathcart A; Barbosa A; Cayphas S; Demoitie MA; Mettens P; Heppner DG; Lanar DE
    Infect Immun; 2007 Feb; 75(2):838-45. PubMed ID: 17101665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses.
    Doll KL; Pewe LL; Kurup SP; Harty JT
    J Immunol; 2016 May; 196(10):4253-62. PubMed ID: 27084099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults.
    Sedegah M; Tamminga C; McGrath S; House B; Ganeshan H; Lejano J; Abot E; Banania GJ; Sayo R; Farooq F; Belmonte M; Manohar N; Richie NO; Wood C; Long CA; Regis D; Williams FT; Shi M; Chuang I; Spring M; Epstein JE; Mendoza-Silveiras J; Limbach K; Patterson NB; Bruder JT; Doolan DL; King CR; Soisson L; Diggs C; Carucci D; Dutta S; Hollingdale MR; Ockenhouse CF; Richie TL
    PLoS One; 2011; 6(10):e24586. PubMed ID: 22003383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults.
    Dodoo D; Hollingdale MR; Anum D; Koram KA; Gyan B; Akanmori BD; Ocran J; Adu-Amankwah S; Geneshan H; Abot E; Legano J; Banania G; Sayo R; Brambilla D; Kumar S; Doolan DL; Rogers WO; Epstein J; Richie TL; Sedegah M
    Malar J; 2011 Jun; 10():168. PubMed ID: 21689436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Antigens Derived from
    Pratt-Riccio LR; De Souza Perce-Da-Silva D; Da Costa Lima-Junior J; Pratt Riccio EK; Ribeiro-Alves M; Santos F; Arruda M; Camus D; Druilhe P; Oliveira-Ferreira J; Daniel-Ribeiro CT; Banic DM
    Am J Trop Med Hyg; 2017 Nov; 97(5):1581-1592. PubMed ID: 29016339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.